Jack A. Syage,Matthew A. Dickason,Jennifer A. Sealey Voyksner
申请号：
US16463047
公开号：
US20190307860A1
申请日:
2017.11.20
申请国别(地区):
US
年份:
2019
代理人:
摘要：
A method is provided for reducing the severity and/or frequency of symptoms or clinical manifestations resulting from gluten ingestion by administering to a seropositive patient with symptomatic celiac disease, gluten intolerance, or gluten sensitivity latiglutenase (ALV003) in an amount from about 100 mg to about 1200 mg per day.
